80% of women ignore these early signs of cervical cancer: 4 things you need to know
Cervical cancer is one of the leading cancers that affects millions of women in India and worldwide; however, one needs to understand that cervical cancer can be prevented or treated if it is caught ...
Merck director Inge G. Thulin acquires $249,999 in stock
Co., Inc. (NYSE:MRK), recently purchased 2,832.861 shares of the company's common stock. The acquisition, valued at approximately $249,999, was completed at a price of $88.25 per share. Following this ...
Hosted on MSN11h
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?
Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...
WDET14h
Doctor says HPV vaccine and routine screenings aid against cervical cancer
Gynecologic oncologist Dr. John Wallbillich says people often don't have symptoms of cervical cancer, so it's important to ...
Medscape1d
HPV Vaccine ‘Very Promising’ for Nixing Precancerous Lesions
A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...
The Gazette1d
Capitol Notebook: Funding boost for food assistance program advances
DES MOINES — State funding for the Double up Food Bucks Program, which provides a one-to-one match to Supplemental Nutrition ...
Iowa Capital Dispatch1d
Bill would require parental consent for children’s HPV vaccine
The bill proposes reversing a section in Iowa law that allows minors to personally consent to get the HPV vaccine without ...
Fact-checking Warren's claim about RFK Jr.'s work on vaccine lawsuits
During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Should You Pick MRK Stock At $90?
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
Merck’s Gardasil Halt Shows Blockbuster Shots’ Dilemma in China
Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...
Merck Shares Hit After Guidance Falls Short, Gardasil Challenge
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...